[1]
Burianov, O., Khimion, L., Omelchenko, T. and Vakulych, M. 2021. Evidence, Efficasy and Safety of the Chondroprotective Parapharmaceuticals in Treatment of the Early Stages of Osteoarthritis. Family medicine. 2-3 (Jul. 2021), 34–42. DOI:https://doi.org/10.30841/2307-5112.2-3.2021.240762.